Literature DB >> 34101973

The statistical risk of diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2 vaccination.

Micol G Cittone1,2, Raphael Battegay3, Adalgisa Condoluci1,2, Lodovico Terzi di Bergamo2, Eliana Fernandes1, Elena Galfetti1, Roberta Noseda4, Anne Leuppi-Taegtmeyer5, Beatrice Drexler3, Ceschi Alessandro4,6, Dimitrios A Tsakiris3, Christoph T Berger7,8, Genevieve Favre9, Thomas Martin10, Wolfgang Korte10, Lukas Graf10, Maria Martinez11, Bernhard Gerber1,12.   

Abstract

We read with interest the case report by Radwi et al. of a 69 year-old man with acquired hemophilia A (AHA) following vaccination with the Pfizer-BioNTech SARS CoV-2 mRNA vaccine (1). The publication prompted us to perform a survey within the Working Party Haemostasis of the Swiss Society of Hematology to detect similar cases in Switzerland. The survey led to the identification of three cases of AHA in Switzerland between December 23rd 2020 and April 30th 2021. This article is protected by copyright. All rights reserved.

Entities:  

Year:  2021        PMID： 34101973     DOI： 10.1111/jth.15421

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


  9 in total

1.  Acquired hemophilia A after vaccination against SARS-CoV-2 with the mRNA-1273 (Moderna) vaccine.

Authors:  Ava Melmed; Andrew Kovoor; Korie Flippo
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-05-23

2.  Case Report: Acquired Haemophilia A Following mRNA-1273 Booster Vaccination Against SARS-CoV-2 With Concurrent Diagnosis of Pleomorphic Dermal Sarcoma.

Authors:  Marlene Plüß; Christina Mitteldorf; Christoph Johannes Szuszies; Björn Tampe
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

3.  Four cases of acquired hemophilia A following immunization with mRNA BNT162b2 SARS-CoV-2 vaccine.

Authors:  Maria Cristina Leone; Simone Canovi; Annalisa Pilia; Annamaria Casali; Luca Depietri; Tommaso Fasano; Rossana Colla; Angelo Ghirarduzzi
Journal:  Thromb Res       Date:  2022-01-20       Impact factor: 3.944

4.  Acquired Hemophilia A Post-COVID-19 Vaccination: A Case Report and Review.

Authors:  Hussam Al Hennawi; Mohammad K Al Masri; Mohamad Bakir; Mohieddin Albarazi; Feras Jazaeri; Talal N Almasri; Sami J Shoura; Abdul Rahman R Barakeh; Abdulrahman Taftafa; Muhammad K Khan; Henry I Zaleski
Journal:  Cureus       Date:  2022-02-04

5.  Case of acquired haemophilia a in Southeast Asia following COVID-19 vaccine.

Authors:  Lee Ai Vuen; Evelyn Aun Su-Yin; Ahlam Naila Kori; T M Shah
Journal:  BMJ Case Rep       Date:  2022-03-09

6.  First and fatal case of autoimmune acquired factor XIII/13 deficiency after COVID-19/SARS-CoV-2 vaccination.

Authors:  Saori Shimoyama; Yuji Kanisawa; Kento Ono; Masayoshi Souri; Akitada Ichinose
Journal:  Am J Hematol       Date:  2021-12-11       Impact factor: 10.047

7.  Acquired Hemophilia A: A possibly fatal complication of SARS-COV-2 infection.

Authors:  Hasan Fareed Siddiqui; Taymmia Ejaz; Aisha Fareed Siddiqui; Fahd Niaz Shaikh
Journal:  Ann Med Surg (Lond)       Date:  2022-07-31

8.  Acquired hemophilia following COVID-19 vaccination: Case report and review of literature.

Authors:  Michiel Happaerts; Thomas Vanassche
Journal:  Res Pract Thromb Haemost       Date:  2022-09-09

9.  Investigating potential mechanisms underlying FVIII inhibition in acquired hemophilia A associated with mRNA COVID-19 vaccines.

Authors:  Julia R Hirsiger; Maria Martinez; Dimitrios A Tsakiris; Micol G Cittone; Lukas Graf; Johannes Oldenburg; Behnaz Pezeshkpoor; Mike Recher; Jens Mueller; Bernhard Gerber; Christoph T Berger
Journal:  J Thromb Haemost       Date:  2022-02-13       Impact factor: 16.036
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.